Meanwhile, Nobiletin resist immune evasion by modulating miR-197/STAT3/PD-L1 signalling in non-small cell lung cancer (NSCLC) cells (Sp et al. 2021). This evidence concerns the gene STAT3 and non-small cell lung carcinoma.